Summary
This review combined 27 studies of nearly 8,000 people who had gender surgery and estimated that about 1% regretted it. The authors concluded regret is extremely rare and credited better screening of patients. The 1% figure is now widely quoted. But the authors themselves say the evidence underneath is weak: most studies were rated poor or fair, almost none used tested ways of measuring regret, and results varied a lot between studies. Critics point out that people were often followed for only one or two years, while regret typically shows up after about eight years. Many people were lost track of (36% in the largest study), and some numbers were copied wrongly. Most people studied were adults treated under older, stricter rules. The 1% is best seen as a minimum drawn from incomplete data, not a reliable regret rate for today's patients.
Key findings
- レビューには、14か国の7,928人の手術患者をカバーする27件の研究が含まれていました。67%が男性から女性、33%が女性から男性への手術で、ノンバイナリーと記録された患者は1人だけでした。
- 全体では、約1%の患者が手術を後悔しており(おそらく1%未満から2%の間)、研究の間で結果は大きく異なりました。後悔を報告したのは合計77人でした。
- 後悔は、女性から男性への手術と乳房切除の後で1%未満、男性から女性への手術の後で1%、膣を作る手術の後で2%でした。
- 後悔の最も多い理由は、新しい性別役割で家族や社会に受け入れられにくいことで、次いで手術や身体的な結果の不良でした。
- ほぼすべての研究が独自の質問や聞き取りを使用し、大半は質が悪いか普通と評価され、追跡は1年未満から9年までと幅がありました。
- 後悔の少ない研究のほうが公表されやすいという兆候があり、これを調整すると推定値は1%から0.5%に下がりました。
- 2022年の訂正は、著者らがレビューをやり直した後に表と図を修正しました。公表された書簡(Expósito-CamposとD'Angelo 2021、Bewley 2022)は、その方法と結論に異議を唱えました。
Abstract
Background: There is an unknown percentage of transgender and gender non-confirming individuals who undergo gender-affirmation surgeries (GAS) that experiences regret. Regret could lead to physical and mental morbidity and questions the appropriateness of these procedures in selected patients. The aim of this study was to evaluate the prevalence of regret in transgender individuals who underwent GAS and evaluate associated factors.
Methods: A systematic review of several databases was conducted. Random-effects meta-analysis, meta-regression, and subgroup and sensitivity analyses were performed.
Results: A total of 27 studies, pooling 7928 transgender patients who underwent any type of GAS, were included. The pooled prevalence of regret after GAS was 1% (95% CI <1%-2%). Overall, 33% underwent transmasculine procedures and 67% transfemenine procedures. The prevalence of regret among patients undergoing transmasculine and transfemenine surgeries was <1% (IC <1%-<1%) and 1% (CI <1%-2%), respectively. A total of 77 patients regretted having had GAS. Twenty-eight had minor and 34 had major regret based on Pfäfflin's regret classification. The majority had clear regret based on Kuiper and Cohen-Kettenis classification.
Conclusions: Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.
Conclusion
Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.